Bayer is contesting the FDA's actions in reducing the use of antibiotics for non-therapeutic purposes, a battle which should tie the hands of the FDA for years. 

The company's slogan, bye the bye, is "Expertise with Responsibility."

Ho, hum.  Let us help them understand the meaning of "Expertise with Responsiblity" at

http://www.bayer.com/kontakt/mailform_ot_en.html

If you prefer to write, the address is:

Bayer AG
51368 Leverkusen
Germany

Werner Wenning has been Chairman of the Board of Management of Bayer AG since April 26, 2002. He is Chairman of the Board Committee for Corporate Coordination and a member of the Board Committee for Finance.

Klaus Kühn has been a member of the Board of Management of Bayer AG since May 1, 2002. He is Chairman of the Board Committee for Finance and a member of the Board Committees for Corporate Coordination and Human Resources


Dr. Attila Molnar, who was appointed to the Board of Management effective April 1, 1999, is a member of the Board Committees for Human Resources, and for Technology and Environment. He is also the representative for the Agriculture segment and for the North America and Mexico region.

Dr. Frank Morich has been a member of the Board of Management of Bayer AG since May 1, 2000. He is the representative for the Health Care segment and Chairman of the Board Committee for Research and Development. He is also a member of the Board Committees for Marketing, Materials Management and Information Processing, and for Technology and Environment. Effective July 1, 2002, he will be Chairman of the Board of Management of Bayer HealthCare AG.


Dr. Udo Oels has been a member of the Board of Management of Bayer AG since February 1, 1996. He is Chairman of the Board Committee for Technology and Environment and a member of the Board Committees for Research and Development and Corporate Coordination. He is also the representative for the China region.

Dr. Richard Pott has been a member of the Board of Management of Bayer AG since May 1, 2002. He is Labor Director, Chairman of the Board Committee for Human Resources and a member of the Board Committees for Research and Development, and for Marketing, Materials Management and Information Processing. He is also representative for the Chemicals business segment and the Europe region.

Werner Spinner was appointed to the Board of Management of Bayer AG effective February 1, 1998. He is Chairman of the Board Committee for Marketing, Materials Management and Information Processing and a member of the Board Committee for Finance. He is also the representative for the Polymers business segment, the Asia/Pacific region and for Bayer's corporate eCommerce project.

Strange that a European company would fight U.S. laws when Europeans are so very aware of the dangers of antibiotic resistance.

Peggy Murdock